Loading Nifty 50, Nifty Bank, and Sensex…
Molbio Diagnostics Limited
MOLBIO · Corporate filings
NSE
Molbio Diagnostics Limited
MOLBIO · NSE · Healthcare
₹1,493.20
7.11%
As of 13 Nov 2026
Molbio Diagnostics Limited (MOLBIO) is listed on NSE in the Healthcare sector. It last traded at ₹1,493.20, up 7.11% on the session.
Research output is rule-based and informational only. It is not investment advice.
Analytics for MOLBIO are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Molbio Diagnostics Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Insider trading
Announcement
Market deal
Bulk deal - BUY - 590,709 shares
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
No corporate actions available right now.
Board Meetings
05 Nov 2026
Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
25 Sep 2026
Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.
05 Sep 2026
Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
27 Aug 2026
Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.